Vivani Medical, Inc. (VANI:NASDAQ) closed at $1.11 on October 23, 2026, up 1.83% on the day. The stock trades 38.7% below its 52-week high of $1.81 and 20.3% above its 52-week low of $0.923. Over the past year, it lost 31.5%. Vivani Medical, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, VANI closed higher on 102 days (40%). Its best day was July 8, 2026 (+18.52%) and its worst was July 10, 2026 (-12.82%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 2 times.
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
Find more stocks like VANI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.